Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors-Reference-Cited by-同舟云学术

Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors

Published:2011-07 Issue:1 Volume:122 Page:163-170
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Basha Riyaz,Ingersoll Susan B.,Sankpal Umesh T.,Ahmad Sarfraz,Baker Cheryl H.,Edwards John R.,Holloway Robert W.,Kaja Sumanth,Abdelrahim Maen

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference47 articles.

1. Cancer Statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Expression of scatter factor and c-met receptor in benign and malignant breast tissue;Jin;Cancer,1997

3. Frequent amplification of the c-met gene in scirrhous type stomach cancer;Kuniyasu;Biochem Biophys Res Commun,1992

4. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice;Lamszus;Lab Invest,1997

5. The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro;Medico;Mol Biol Cell,1996

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fenamates: Forgotten treasure for cancer treatment and prevention: Mechanisms of action, structural modification, and bright future;Medicinal Research Reviews;2024-08-22

2. Specificity protein 1/3 regulate T-cell acute lymphoblastic leukemia cell proliferation and apoptosis through β-catenin by acting as targets of miR-495-3p;Annals of Hematology;2024-06-03

3. The Relationship between Trop-2, Chemotherapeutic Drugs, and Chemoresistance;International Journal of Molecular Sciences;2023-12-20

4. New tolfenamic acid derivatives with hydrazine-1-carbothioamide and 1,3,4-oxadiazole moieties targeting VEGFR: synthesis, in silico studies, and in vitro anticancer assessment;Medicinal Chemistry Research;2023-08-18

5. Self-assembly nanoplatform of platinum (Ⅳ) prodrug for enhanced ovarian cancer therapy;Materials Today Bio;2023-08